ARCHIVES

FDA Approves New Indication For Anticoagulant Frangmin

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

Upon, Panel Lean To Anecdotal Laetrile Study

August 12, 1977

HPV Can Affect Response To Radiation Therapies

September 28, 2012

Vanderbilt-Ingram Cancer Center Wins NCI’s Comprehensive Designation.

March 16, 2001

Enck New ACCC President, King President Elect

March 20, 1987

Study Finds Physician Referral By Centers Fraught With Problems, Potential Dangers

July 23, 1976